Sign In
Sign In
Ozempic is the version of Novo Nordisk’s semaglutide drug aimed at people with diabetes. Credit: K KStock/Adobe StockResource Center
Information Brief
Sponsored by Corebridge Financial
In Focus: Government Market Segment
Download this Q&A to learn about impactful trends, advice for plan sponsors and participants, and the role that Corebridge plays in moving financial futures forward for government plan sponsors and employees.
eBook
Sponsored by Nonstop Administration and Insurance Services, Inc.
Broker E-book: MERP Compliance Considerations
Read on to get the need-to-know compliance considerations before you offer a Medical Expense Reimbursement Plan (MERP).
eBook
Sponsored by Vetster
Future Proofing Your Workforce: Unlocking Employee Loyalty With Pet-Friendly Benefits
Today’s employees are more likely than ever to seek workplaces that support their lives as pet parents. Discover how offering pet-friendly benefits can boost employee loyalty, improve office attendance, and enhance overall satisfaction in this eBook.
BenefitsPRO
Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2024 ALM Global, LLC. All Rights Reserved.